Cargando…
Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?
End-stage liver disease is responsible for 30,000 deaths per year in the United States alone, and it is continuing to increase every year. With liver transplantation the only curative treatment currently available, new therapies are in great demand. Mesenchymal stem cells (MSC) offer an opportunity...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Physiological Society
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652139/ https://www.ncbi.nlm.nih.gov/pubmed/26316587 http://dx.doi.org/10.1152/ajpgi.00036.2015 |